Related references
Note: Only part of the references are listed.Incidence of vancomycin-resistant enterococci (VRE) infection in high-risk febrile neutropenic patients colonized with VRE
John B. Bossaer et al.
SUPPORTIVE CARE IN CANCER (2011)
New Antimicrobial Agents Approved by the U.S. Food and Drug Administration from 2007 to 2009 and New Indications for Previously Approved Agentsa
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
The Changing Epidemiology of Vancomycin-Resistant Enterococcus (VRE) Bacteremia in Allogeneic Hematopoietic Stem Cell Transplant (HSCT) Recipients
Mini Kamboj et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Overview perspective of bacterial resistance
Guilherme H. Furtado et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2010)
Organization of the biosynthetic genes encoding deoxyactagardine B (DAB), a new lantibiotic produced by Actinoplanes liguriae NCIMB41362
Steven Boakes et al.
JOURNAL OF ANTIBIOTICS (2010)
Antibiotic discovery in the twenty-first century: current trends and future perspectives
Stefano Donadio et al.
JOURNAL OF ANTIBIOTICS (2010)
Future antibiotics scenarios: is the tide starting to turn?
Ursula Theuretzbacher
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Determining the structure and mode of action of microbisporicin, a potent lantibiotic active against multiresistant pathogens
Franca Castiglione et al.
CHEMISTRY & BIOLOGY (2008)
Risk of vancomycin-resistant Enterococcus (VRE) bloodstream infection among patients colonized with VRE
Chamion N. Olivier et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2008)
Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003
RM Klevens et al.
CLINICAL INFECTIOUS DISEASES (2006)
Staphylococcus aureus endocarditis -: A consequence of medical progress
VG Fowler et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2005)
Infective endocarditis - Diagnosis, antimicrobial therapy, and management of complications - A statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association
LM Baddour et al.
CIRCULATION (2005)
Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus
DL Higgins et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Efficacy of dalbavancin against methicillin-resistant Staphylococcus aureus in the rat granuloma pouch infection model
D Jabés et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Worldwide assessment of linezolid's clinical safety and tolerability: Comparator-controlled phase III studies
E Rubinstein et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Share Paper
